Horizon Bancorp’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$140K Hold
152
0.07% 96
2025
Q4
$163K Hold
152
0.08% 87
2025
Q3
$116K Hold
152
0.06% 99
2025
Q2
$118K Hold
152
0.06% 109
2025
Q1
$126K Hold
152
0.07% 85
2024
Q4
$117K Sell
152
-136
-47% -$113K 0.06% 93
2024
Q3
$255K Sell
288
-4
-1% -$3.6K 0.12% 51
2024
Q2
$264K Sell
292
-22
-7% -$17.6K 0.13% 42
2024
Q1
$245K Sell
314
-7
-2% -$4.98K 0.12% 46
2023
Q4
$187K Hold
321
0.09% 55
2023
Q3
$172K Sell
321
-274
-46% -$141K 0.11% 49
2023
Q2
$279K Sell
595
-2
-0.3% -$839 0.18% 27
2023
Q1
$205K Sell
597
-63
-10% -$21.2K 0.13% 22
2022
Q4
$241K Buy
+660
New +$234K 0.13% 41
2020
Q3
$585K Buy
3,953
+350
+10% +$54.2K 0.83% 28
2020
Q2
$592K Sell
3,603
-1,269
-26% -$195K 0.64% 24
2020
Q1
$676K Sell
4,872
-1,030
-17% -$142K 1.05% 23
2019
Q4
$776K Buy
+5,902
New +$684K 0.73% 33

Other funds holding LLY

Horizon Bancorp's LLY Position: Q1 2026 in Review

Horizon Bancorp held its Eli Lilly (LLY) position steady in Q1 2026 at 152 shares worth $140K. The position accounts for 0.07% of the portfolio, ranked #96.

Horizon Bancorp first reported a position in LLY in Q4 2019 and has held it in 18 quarters since. The position peaked at $776K in Q4 2019. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Horizon Bancorp held 152 shares of Eli Lilly worth $140K as of Q1 2026.
  • Horizon Bancorp left its Eli Lilly share count unchanged in Q1 2026.
  • Eli Lilly made up 0.07% of Horizon Bancorp's portfolio in Q1 2026, its #96 holding.
  • Horizon Bancorp first reported a position in Eli Lilly in Q4 2019 and has held it in 18 quarters since.
  • Horizon Bancorp's Eli Lilly position peaked at $776K in Q4 2019.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Horizon Bancorp's 13F filing for Q1 2026, filed 22 Apr 2026.